The University of Chicago Header Logo

Connection

Narutoshi Hibino to Animals

Back to Details
This is a "connection" page, showing publications Narutoshi Hibino has written about Animals.
Narutoshi Hibino
Connection Strength
1.275
Animals
  1. Nanofiber-coated, tacrolimus-eluting sutures inhibit post-operative neointimal hyperplasia in rats. J Control Release. 2023 01; 353:96-104.
    View in: PubMed
    Score: 0.056
  2. Extruded poly (glycerol sebacate) and polyglycolic acid vascular graft forms a neoartery. J Tissue Eng Regen Med. 2022 04; 16(4):346-354.
    View in: PubMed
    Score: 0.053
  3. Fast-Degrading Tissue-Engineered Vascular Grafts Lead to Increased Extracellular Matrix Cross-Linking Enzyme Expression. Tissue Eng Part A. 2021 11; 27(21-22):1368-1375.
    View in: PubMed
    Score: 0.052
  4. Different degradation rates of nanofiber vascular grafts in small and large animal models. J Tissue Eng Regen Med. 2020 02; 14(2):203-214.
    View in: PubMed
    Score: 0.046
  5. In vivo implantation of 3-dimensional printed customized branched tissue engineered vascular graft in a porcine model. J Thorac Cardiovasc Surg. 2020 05; 159(5):1971-1981.e1.
    View in: PubMed
    Score: 0.045
  6. Cardiac regeneration using human-induced pluripotent stem cell-derived biomaterial-free 3D-bioprinted cardiac patch in vivo. J Tissue Eng Regen Med. 2019 11; 13(11):2031-2039.
    View in: PubMed
    Score: 0.045
  7. A Net Mold-Based Method of Biomaterial-Free Three-Dimensional Cardiac Tissue Creation. Tissue Eng Part C Methods. 2019 04; 25(4):243-252.
    View in: PubMed
    Score: 0.044
  8. Formation of Neoarteries with Optimal Remodeling Using Rapidly Degrading Textile Vascular Grafts. Tissue Eng Part A. 2019 04; 25(7-8):632-641.
    View in: PubMed
    Score: 0.043
  9. Oversized Biodegradable Arterial Grafts Promote Enhanced Neointimal Tissue Formation. Tissue Eng Part A. 2018 08; 24(15-16):1251-1261.
    View in: PubMed
    Score: 0.041
  10. 3D and 4D Bioprinting of the Myocardium: Current Approaches, Challenges, and Future Prospects. Biomed Res Int. 2018; 2018:6497242.
    View in: PubMed
    Score: 0.041
  11. In vivo therapeutic applications of cell spheroids. Biotechnol Adv. 2018 Mar - Apr; 36(2):494-505.
    View in: PubMed
    Score: 0.040
  12. Review of Vascular Graft Studies in Large Animal Models. Tissue Eng Part B Rev. 2018 04; 24(2):133-143.
    View in: PubMed
    Score: 0.040
  13. 3D bioprinting using stem cells. Pediatr Res. 2018 01; 83(1-2):223-231.
    View in: PubMed
    Score: 0.040
  14. Bilateral Arteriovenous Shunts as a Method for Evaluating Tissue-Engineered Vascular Grafts in Large Animal Models. Tissue Eng Part C Methods. 2017 11; 23(11):728-735.
    View in: PubMed
    Score: 0.039
  15. Biomaterial-Free Three-Dimensional Bioprinting of Cardiac Tissue using Human Induced Pluripotent Stem Cell Derived Cardiomyocytes. Sci Rep. 2017 07 04; 7(1):4566.
    View in: PubMed
    Score: 0.039
  16. Role of Bone Marrow Mononuclear Cell Seeding for Nanofiber Vascular Grafts. Tissue Eng Part A. 2018 01; 24(1-2):135-144.
    View in: PubMed
    Score: 0.039
  17. Preclinical study of patient-specific cell-free nanofiber tissue-engineered vascular grafts using 3-dimensional printing in a sheep model. J Thorac Cardiovasc Surg. 2017 04; 153(4):924-932.
    View in: PubMed
    Score: 0.037
  18. Tissue-Engineered Small Diameter Arterial Vascular Grafts from Cell-Free Nanofiber PCL/Chitosan Scaffolds in a Sheep Model. PLoS One. 2016; 11(7):e0158555.
    View in: PubMed
    Score: 0.036
  19. Novel Association of miR-451 with the Incidence of TEVG Stenosis in a Murine Model. Tissue Eng Part A. 2016 Jan; 22(1-2):75-82.
    View in: PubMed
    Score: 0.035
  20. The innate immune system contributes to tissue-engineered vascular graft performance. FASEB J. 2015 Jun; 29(6):2431-8.
    View in: PubMed
    Score: 0.033
  21. Something to consider: porcine intestinal submucosa as a biologic scaffold, not a simple patch. J Thorac Cardiovasc Surg. 2014 Oct; 148(4):1767-9.
    View in: PubMed
    Score: 0.032
  22. Evaluation of the use of an induced puripotent stem cell sheet for the construction of tissue-engineered vascular grafts. J Thorac Cardiovasc Surg. 2012 Mar; 143(3):696-703.
    View in: PubMed
    Score: 0.027
  23. A critical role for macrophages in neovessel formation and the development of stenosis in tissue-engineered vascular grafts. FASEB J. 2011 Dec; 25(12):4253-63.
    View in: PubMed
    Score: 0.026
  24. Comparison of human bone marrow mononuclear cell isolation methods for creating tissue-engineered vascular grafts: novel filter system versus traditional density centrifugation method. Tissue Eng Part C Methods. 2011 Oct; 17(10):993-8.
    View in: PubMed
    Score: 0.026
  25. Tissue-engineered vascular grafts form neovessels that arise from regeneration of the adjacent blood vessel. FASEB J. 2011 Aug; 25(8):2731-9.
    View in: PubMed
    Score: 0.025
  26. The tissue-engineered vascular graft using bone marrow without culture. J Thorac Cardiovasc Surg. 2005 May; 129(5):1064-70.
    View in: PubMed
    Score: 0.017
  27. Monolithic silicon for high spatiotemporal translational photostimulation. Nature. 2024 Feb; 626(8001):990-998.
    View in: PubMed
    Score: 0.015
  28. Off-the-shelf, heparinized small diameter vascular graft limits acute thrombogenicity in a porcine model. Acta Biomater. 2022 10 01; 151:134-147.
    View in: PubMed
    Score: 0.014
  29. Noncanonical Notch signals have opposing roles during cardiac development. Biochem Biophys Res Commun. 2021 11 05; 577:12-16.
    View in: PubMed
    Score: 0.013
  30. [Cryopreservation of vascular mixed cell for tissue engineering in cardiovascular surgery]. Kyobu Geka. 2001 Jun; 54(6):479-84.
    View in: PubMed
    Score: 0.013
  31. Biomimetic Model of Contractile Cardiac Tissue with Endothelial Networks Stabilized by Adipose-Derived Stromal/Stem Cells. Sci Rep. 2020 05 20; 10(1):8387.
    View in: PubMed
    Score: 0.012
  32. Assessment of decellularized pericardial extracellular matrix and poly(propylene fumarate) biohybrid for small-diameter vascular graft applications. Acta Biomater. 2020 07 01; 110:68-81.
    View in: PubMed
    Score: 0.012
  33. Spontaneous reversal of stenosis in tissue-engineered vascular grafts. Sci Transl Med. 2020 04 01; 12(537).
    View in: PubMed
    Score: 0.012
  34. Regenerative and durable small-diameter graft as an arterial conduit. Proc Natl Acad Sci U S A. 2019 06 25; 116(26):12710-12719.
    View in: PubMed
    Score: 0.011
  35. Tissue-engineered cardiac patch seeded with human induced pluripotent stem cell derived cardiomyocytes promoted the regeneration of host cardiomyocytes in a rat model. J Cardiothorac Surg. 2016 Dec 01; 11(1):163.
    View in: PubMed
    Score: 0.009
  36. TGF-ß receptor 1 inhibition prevents stenosis of tissue-engineered vascular grafts by reducing host mononuclear phagocyte activation. FASEB J. 2016 07; 30(7):2627-36.
    View in: PubMed
    Score: 0.009
  37. Rational design of an improved tissue-engineered vascular graft: determining the optimal cell dose and incubation time. Regen Med. 2016 Mar; 11(2):159-67.
    View in: PubMed
    Score: 0.009
  38. 3D-Printed Biodegradable Polymeric Vascular Grafts. Adv Healthc Mater. 2016 Feb 04; 5(3):319-325.
    View in: PubMed
    Score: 0.009
  39. Effect of cell seeding on neotissue formation in a tissue engineered trachea. J Pediatr Surg. 2016 Jan; 51(1):49-55.
    View in: PubMed
    Score: 0.009
  40. Cilostazol, Not Aspirin, Prevents Stenosis of Bioresorbable Vascular Grafts in a Venous Model. Arterioscler Thromb Vasc Biol. 2015 Sep; 35(9):2003-10.
    View in: PubMed
    Score: 0.008
  41. TGFßR1 inhibition blocks the formation of stenosis in tissue-engineered vascular grafts. J Am Coll Cardiol. 2015 Feb 10; 65(5):512-4.
    View in: PubMed
    Score: 0.008
  42. Contrasting biofunctionalization strategies for the enhanced endothelialization of biodegradable vascular grafts. Biomacromolecules. 2015 Feb 09; 16(2):437-46.
    View in: PubMed
    Score: 0.008
  43. Reinforced pericardium as a hybrid material for cardiovascular applications. Tissue Eng Part A. 2014 Nov; 20(21-22):2807-16.
    View in: PubMed
    Score: 0.008
  44. Transplantation of pulmonary valve using a mouse model of heterotopic heart transplantation. J Vis Exp. 2014 Jul 23; (89).
    View in: PubMed
    Score: 0.008
  45. Implantation of inferior vena cava interposition graft in mouse model. J Vis Exp. 2014 Jun 04; (88).
    View in: PubMed
    Score: 0.008
  46. Vessel bioengineering. Circ J. 2014; 78(1):12-9.
    View in: PubMed
    Score: 0.008
  47. Development and assessment of a biodegradable solvent cast polyester fabric small-diameter vascular graft. J Biomed Mater Res A. 2014 Jun; 102(6):1972-1981.
    View in: PubMed
    Score: 0.007
  48. Strategies and techniques to enhance the in situ endothelialization of small-diameter biodegradable polymeric vascular grafts. Tissue Eng Part B Rev. 2013 Aug; 19(4):292-307.
    View in: PubMed
    Score: 0.007
  49. Characterization of the natural history of extracellular matrix production in tissue-engineered vascular grafts during neovessel formation. Cells Tissues Organs. 2012; 195(1-2):60-72.
    View in: PubMed
    Score: 0.007
  50. Determining the fate of seeded cells in venous tissue-engineered vascular grafts using serial MRI. FASEB J. 2011 Dec; 25(12):4150-61.
    View in: PubMed
    Score: 0.006
  51. Transforming growth factor beta expression by human vascular cells inhibits interferon gamma production and arterial media injury by alloreactive memory T cells. Am J Transplant. 2011 Nov; 11(11):2332-41.
    View in: PubMed
    Score: 0.006
  52. Vascular tissue engineering: towards the next generation vascular grafts. Adv Drug Deliv Rev. 2011 Apr 30; 63(4-5):312-23.
    View in: PubMed
    Score: 0.006
  53. Tissue-engineered vascular grafts: does cell seeding matter? J Pediatr Surg. 2010 Jun; 45(6):1299-305.
    View in: PubMed
    Score: 0.006
  54. Tissue-engineered vascular grafts transform into mature blood vessels via an inflammation-mediated process of vascular remodeling. Proc Natl Acad Sci U S A. 2010 Mar 09; 107(10):4669-74.
    View in: PubMed
    Score: 0.006
  55. Tissue-engineered arterial grafts: long-term results after implantation in a small animal model. J Pediatr Surg. 2009 Jun; 44(6):1127-32; discussion 1132-3.
    View in: PubMed
    Score: 0.006
  56. Tissue-engineered vascular grafts demonstrate evidence of growth and development when implanted in a juvenile animal model. Ann Surg. 2008 Sep; 248(3):370-7.
    View in: PubMed
    Score: 0.005
  57. A novel method to reduce pericardial adhesion: a combination technique with hyaluronic acid biocompatible membrane. J Thorac Cardiovasc Surg. 2008 Apr; 135(4):850-6.
    View in: PubMed
    Score: 0.005
  58. [Clinical practice of transplantation of regenerated blood vessels using bone marrow cells]. Nihon Naika Gakkai Zasshi. 2003 Sep 10; 92(9):1776-80.
    View in: PubMed
    Score: 0.004
  59. Tissue-engineered vascular autograft: inferior vena cava replacement in a dog model. Tissue Eng. 2001 Aug; 7(4):429-39.
    View in: PubMed
    Score: 0.003
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.